4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001273351-26-000006
CHIEF ACCOUNTING OFFICER sold 20,000 shares at an average $101.38 ($2,027,646)
- CHIEF ACCOUNTING OFFICER acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
CARR EDWARD · CHIEF ACCOUNTING OFFICER
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-17 | Exercise or conversion : show line 1 in the form 10b5-1 | +20,000 | $17.88 | $357,600 | 20,000 | D |
| 2026-09-17 | Sale : show line 2 in the form 10b5-1 | −7,928 | $100.43 | $796,209 | 12,072 | D |
| 2026-09-17 | Sale : show line 3 in the form 10b5-1 | −6,771 | $101.37 | $686,376 | 5,301 | D |
| 2026-09-17 | Sale : show line 4 in the form 10b5-1 | −3,501 | $102.39 | $358,467 | 1,800 | D |
| 2026-09-17 | Sale : show line 5 in the form 10b5-1 | −1,100 | $103.20 | $113,520 | 700 | D |
| 2026-09-17 | Sale : show line 6 in the form 10b5-1 | −700 | $104.39 | $73,073 | 0 | D |
| Open-market sales · 20,000 sh · avg $101.38 · $2,027,646 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-09-17 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (Right to Buy) | −20,000 | 43,818 | D |
Loading xslF345X06/ownership.xml…